Health Canada
- Status: approved
whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose (whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Sinovac Biotech Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.